Literature DB >> 21627570

Plasma antioxidants are associated with impaired lung function and COPD exacerbations in smokers.

Michael E Nicks1, Maureen M O'Brien, Russell P Bowler.   

Abstract

Low molecule weight antioxidants such as uric acid (UA), glutathione (GSH), and ascorbate (ASC) counter the effects of oxidants produced by cigarette smoke. Although dietary intake of foods rich in antioxidants has been associated with a reduced risk of smokers developing chronic obstructive pulmonary disease (COPD), the association between plasma antioxidants and COPD is less clear. In this cross-sectional study we investigated the relationship among plasma antioxidants and COPD phenotypes (severity of airflow obstruction on spirometry and history of exacerbations) in 136 smokers with normal lung function and 367 smokers with COPD. In the multivariate analysis, a lower plasma UA was associated with more severe COPD (P < 0.002) and a lower GSH was associated with a history of COPD exacerbations (P = 0.03); ASC was not associated with any COPD phenotypes. This suggests that antioxidant balance is impaired in smokers with obstruction on spirometry or a history of COPD exacerbations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21627570      PMCID: PMC4486075          DOI: 10.3109/15412555.2011.579202

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  46 in total

1.  The interrelationship between markers of inflammation and oxidative stress in chronic obstructive pulmonary disease: modulation by inhaled steroids and antioxidant.

Authors:  A M Sadowska; F J van Overveld; D Górecka; A Zdral; M Filewska; U A Demkow; C Luyten; E Saenen; J Zielinski; W A De Backer
Journal:  Respir Med       Date:  2005-02       Impact factor: 3.415

2.  Glutathione in foods listed in the National Cancer Institute's Health Habits and History Food Frequency Questionnaire.

Authors:  D P Jones; R J Coates; E W Flagg; J W Eley; G Block; R S Greenberg; E W Gunter; B Jackson
Journal:  Nutr Cancer       Date:  1992       Impact factor: 2.900

3.  Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes.

Authors:  P S Samiec; C Drews-Botsch; E W Flagg; J C Kurtz; P Sternberg; R L Reed; D P Jones
Journal:  Free Radic Biol Med       Date:  1998-03-15       Impact factor: 7.376

4.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

Review 5.  Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease.

Authors:  I Rahman; W MacNee
Journal:  Am J Physiol       Date:  1999-12

6.  Increased glutathione disulfide and nitrosothiols in sputum supernatant of patients with stable COPD.

Authors:  Kai Michael Beeh; Jutta Beier; Nicole Koppenhoefer; Roland Buhl
Journal:  Chest       Date:  2004-10       Impact factor: 9.410

7.  Developing COPD: a 25 year follow up study of the general population.

Authors:  A Løkke; P Lange; H Scharling; P Fabricius; J Vestbo
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

8.  Systemic poly(ADP-ribose) polymerase-1 activation, chronic inflammation, and oxidative stress in COPD patients.

Authors:  Geja J Hageman; Ingrid Larik; Herman Jan Pennings; Guido R M M Haenen; Emiel F M Wouters; Aalt Bast
Journal:  Free Radic Biol Med       Date:  2003-07-15       Impact factor: 7.376

9.  Antioxidants, oxidative stress, and pulmonary function in individuals diagnosed with asthma or COPD.

Authors:  H M Ochs-Balcom; B J B Grant; P Muti; C T Sempos; J L Freudenheim; R W Browne; S E McCann; M Trevisan; P A Cassano; L Iacoviello; H J Schünemann
Journal:  Eur J Clin Nutr       Date:  2006-02-15       Impact factor: 4.016

Review 10.  Diet and obstructive lung diseases.

Authors:  I Romieu; C Trenga
Journal:  Epidemiol Rev       Date:  2001       Impact factor: 6.222

View more
  22 in total

1.  Plasma cysteine/cystine and glutathione/glutathione disulfide redox potentials in HIV and COPD patients.

Authors:  Walter H Watson; Jeffrey D Ritzenthaler; Paula Peyrani; Timothy L Wiemken; Stephen Furmanek; Andrea M Reyes Vega; Tom J Burke; Yuxuan Zheng; Julio A Ramirez; Jesse Roman
Journal:  Free Radic Biol Med       Date:  2019-07-29       Impact factor: 7.376

2.  COPD and levels of Hsp70 (HSPA1A) and Hsp27 (HSPB1) in plasma and lymphocytes among coal workers: a case-control study.

Authors:  Xiuqing Cui; Jingcai Xing; Yuewei Liu; Yun Zhou; Xin Luo; Zhihong Zhang; Wenhui Han; Tangchun Wu; Weihong Chen
Journal:  Cell Stress Chaperones       Date:  2015-01-27       Impact factor: 3.667

3.  Glutathione Depletion Accelerates Cigarette Smoke-Induced Inflammation and Airspace Enlargement.

Authors:  Neal S Gould; Elysia Min; Jie Huang; Hong Wei Chu; Jim Good; Richard J Martin; Brian J Day
Journal:  Toxicol Sci       Date:  2015-07-06       Impact factor: 4.849

Review 4.  Pharmacological antioxidant strategies as therapeutic interventions for COPD.

Authors:  Irfan Rahman
Journal:  Biochim Biophys Acta       Date:  2011-11-09

5.  Alcohol abuse is associated with enhanced pulmonary and systemic xanthine oxidoreductase activity.

Authors:  Mehdi A Fini; Jeanette Gaydos; Alicia McNally; Vijaya Karoor; Ellen L Burnham
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-24       Impact factor: 5.464

6.  Oxidative/Nitrosative stress and the pathobiology of chronic obstructive pulmonary disease.

Authors:  Rajesh Pandey; Mamta Singh; Udita Singhal; Krishna Bihari Gupta; Surendra Kumar Aggarwal
Journal:  J Clin Diagn Res       Date:  2013-03-01

Review 7.  Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease.

Authors:  Hoi Nam Tse; Cee Zhung Steven Tseng
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-08-06

8.  Serum Uric Acid in Chronic Obstructive Pulmonary Disease: A Hospital Based Case Control Study.

Authors:  Rajlaxmi Sarangi; Nirupama Varadhan; Jyotirmayee Bahinipati; Asha Dhinakaran; Kandasamy Ravichandran
Journal:  J Clin Diagn Res       Date:  2017-09-01

9.  Trolox contributes to Nrf2-mediated protection of human and murine primary alveolar type II cells from injury by cigarette smoke.

Authors:  E M Messier; K Bahmed; R M Tuder; H W Chu; R P Bowler; B Kosmider
Journal:  Cell Death Dis       Date:  2013-04-04       Impact factor: 8.469

10.  Hyperuricemia is a biomarker of early mortality in patients with chronic obstructive pulmonary disease.

Authors:  Xin Zhang; Lijie Liu; Rui Liang; Shoude Jin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.